Streetbeat News

Marketing

AAPL

NFLX

Apple Inc (AAPL) has made significant investments in blockbuster movies, spending $700 million on 'Killers of the Flower Moon,' 'Napoleon,' and 'Argylle,' which collectively grossed $470.4 million worldwide. The company's strategy of releasing films theatrically before streaming them on AppleTV+ has contributed to their profitability and increased subscriber numbers. With 13 Academy Award nominations for its movies, Apple's presence in the entertainment industry is growing. However, an analyst suggests Apple's $1 billion film budget could be better utilized, despite the quality of films attracting demand for AppleTV+.

Portfolio Pulse from Chris Katje

March 08, 2024 | 2:01 pm

COIN

PLTR

TSLA

Cryptocurrencies like Bitcoin, Ethereum, and Dogecoin have seen significant spikes, with Bitcoin nearing all-time highs. The cannabis industry reacts positively to Biden's call for cannabis reform. Cathie Wood sells $13.15M worth of Coinbase shares, opting for Palantir stock instead. Tesla's Bitcoin investment yields a substantial unrealized profit. The S&P 500 surges to a new high, driven by tech giants and improved investor sentiment. Biden's economic policies and calls for cannabis reform mark significant political statements. Tesla faces a valuation drop and legal challenges, while the EV market sees competition from Rivian.

Portfolio Pulse from Akanksha Bakshi

March 08, 2024 | 1:12 pm

SENS

Senseonics Holdings announced that data from its Eversense Post Approval Study will be presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes. This presentation could highlight the effectiveness and safety of the Eversense device, potentially impacting the company's reputation and investor confidence.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 1:07 pm

DMTK

DermTech, Inc. (DMTK) announced the presentation of research abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and the publication of new research in the Journal of Investigative Dermatology. These developments highlight the company's ongoing efforts in dermatological research and its commitment to advancing skin health technologies.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 1:06 pm

TGTX

TG Therapeutics announced its schedule for presenting data on BRIUMVI (ublituximab) for Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting. This event is significant as it may influence the perception of BRIUMVI's efficacy and market potential.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:37 pm

MPU

Mega Matrix announced its plan to launch a $100M 'Mars Content Initiative' over the next three years, aimed at producing short dramas for its platform, FlexTv. This initiative is expected to enhance content variety and attract more viewers to FlexTv.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 12:35 pm

KALV

KalVista Pharmaceuticals announced its plans to present data on HAE (Hereditary Angioedema) attack journey at the 2024 HAEi Regional Conference Americas. This presentation could provide insights into the effectiveness and impact of KalVista's treatments for HAE.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 11:44 am

OPRA

Opera announced that its AI-powered browser will soon receive additional features through a new AI Innovation Program. This initiative aims to enhance the browser's capabilities by integrating more advanced AI technologies.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 11:05 am

RIVN

TSLA

Tesla and Rivian both held significant livestream events, with Tesla's Model 3 update drawing 2.4 million views on X, overshadowing Rivian's R2 SUV unveiling which attracted over 350,000 views across X and YouTube. Despite Tesla's larger social media following, Rivian's R2 generated more focused search interest according to Google Trends. Both companies are competing in similar price brackets with their electric vehicles, with Rivian's R2 and R3 targeting the same market as Tesla's Model Y and Model 3.

Portfolio Pulse from Anan Ashraf

March 08, 2024 | 10:24 am

TSLA

Tesla Inc (NASDAQ:TSLA) has experienced a significant market value decline of $234 billion in 2024, dropping its market cap to just over $550 billion, a 29% decrease in less than 10 weeks. This loss exceeds the market caps of McDonald's, Disney, and Nike combined. Despite a five-fold increase since 2020, Tesla's stock has fallen about 60% from its peak in November 2021. Factors contributing to this decline include reduced demand for electric vehicles, competition in China, and the impact of Federal Reserve's interest rate hikes. Challenges such as a suspected arson at its Giga Berlin factory and significant price reductions in China have further impacted Tesla's performance.

Portfolio Pulse from Benzinga Neuro

March 08, 2024 | 4:15 am